Friday 16th April 2021
Location: William Inglis Hotel | Grand Armee Room
Time: 6:00pm – 9:00pm (AEDT)
To obtain a better understanding of Aortic Stenosis, severity, comorbidities and the importance of timely referrals by discussing patients already treated (case reviews), understanding the differences between valves and how you choose to refer, affects each patient.
Graduated medicine MBBS hons university of Sydney in 1988 with honours. Internship at Royal Prince Alfred hospital in Sydney 1988. Resident medical officer RPAH 1989. Medical registrar 1989-1993. Cardiology training at Alfred Hospital in Melbourne 1994-1995. Completed cardiology training at Royal North Shore hospital 1996 as Senior registrar. RNSH Fellow until June 1997.
Interventional cardiology fellowship at Stanford university medical centre 1997-1998. Staff attending interventional cardiologist 1999-April 2000. Investigator in the PTMR programme and PACIFIC study and co-authored a book chapter on PTMR. Expert in coronary brachytherapy and participated in INHIBIT Study. Consultant to TransVascular inc and participated in the development of PICVA and PICAB procedures. Investigator in DIRECT study and PTMR.
Director of the Coronary unit at Liverpool Hospital from April 2000 until 2013. From 2013, Senior staff cardiologist and Director of Cardiac Catheterisation laboratories at Liverpool Hospital. Interests include novel and complex PCI (CHIP) and acute coronary syndromes, heart failure, antiplatelet and anticoagulants, device therapies, vascular closure devices, intracoronary imaging and cardiogenic shock.
Recognised internationally as CTO-PCI expert and published papers on CTO-PCI. Director of the Asia Pacific CTO club. Served as an investigator in multiple international multicentre clinical trials and also investigator initiated trials. Currently Chair of interventional council of Cardiac society of Australia and New Zealand and member of the organising committee of the ANZET meeting annually. Convener of EPIC since 2006, now in its 13th meeting. Organising committee and co-director or convener of ANZCTO, ANZCCT, Action day, Crossroads meeting.
Appointed in 2018 as Associate Director of AICT-Asia PCR. Has served as Faculty at TCT, EuroPCr, CIT, summer-In-Seattle, CCT, TTT, Topic, ANZET, CSANZ, HK cardiac society, Taiwan cardiac society. Organising committee on Heart failure meetings 2003-2005. Highly experienced in PTMV, BAV, ASD/PFO closure procedures and clinical lead of the TAVI programme at Liverpool Hospital. He has started a distal radial access programme at Liverpool Hospital Sept 2018. He has performed multiple live case demonstrations in high risk, complex PCI as well as CTO-PCI at local and international meetings.
Professor Craig Juergens graduated from the University of New South Wales in 1986 and after Cardiology Training at RPAH, and an Interventional Cardiology Fellowship at Stanford University he established the Interventional Cardiology Service at Liverpool Hospital in 1997.
He was appointed Conjoint Professor UNSW in 2020 and was Department Head at Liverpool from 2011-2021. He established a clinical research unit and a training programme for Interventional Cardiology Fellows.
He has performed Percutaneous Coronary Interventions in numerous countries. Major research interests include interventional cardiology and he has supervised Masters and PhD candidates. He was awarded a Doctorate of Medical Science from the UNSW in 2014.
He has published over 100 papers and has been an invited speaker at national and international meetings. More recently he formed a collaboration of researchers across Southwestern Sydney (ICON) and became Co-Lead of the Cardiac and Vascular CAG for Sphere in 2018.
Together with Dr Sidney Lo he established the TAVI service in 2020 at Liverpool.
He was appointed Director of Medicine at Liverpool Hospital in 2021